Soc. Generale Knock-Out MRK/ DE000CL7PKW8 /
2024-05-22 12:48:17 PM | Chg.+0.02 | Bid1:29:25 PM | Ask1:29:25 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
6.08EUR | +0.33% | 6.06 Bid Size: 10,000 |
6.07 Ask Size: 10,000 |
MERCK KGAA O.N. | 105.0878 - | 2078-12-31 | Call |
GlobeNewswire
1:00 PM
Medicenna to Present Clinical Update on the MDNA11 ABILITY-1 Trial at the Upcoming Sachs 10th Annual...
GlobeNewswire
05-07
CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...
GlobeNewswire
05-06
Press Release Biocartis NV: Biocartis and Merck to Collaborate on Improving Patient Access to Person...
GlobeNewswire
03-04
C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Ger...
GlobeNewswire
2023-12-21
Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed with Phase II Cardiac ...
GlobeNewswire
2023-12-14
ITM Executes License Agreement to Obtain Worldwide Exclusive License for the Clinical Development an...
GlobeNewswire
2023-10-17
ImmunOs Therapeutics Announces Clinical Trial Collaboration with Merck & Co., Inc., Rahway, NJ, USA